Loading...

APC anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418
C57BL/6 mouse splenocytes stained with N418 APC and PK136 PE
  • N418
    C57BL/6 mouse splenocytes stained with N418 APC and PK136 PE
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
117309 25 µg $33
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117310 100 µg $116
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11c antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References

(PubMed link indicates BioLegend citation)
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Narusawa M, et al. 2014. Cancer Immunol Res. 2:568. PubMed
  2. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  3. Lin C, et al. 2020. Cancer Immunol Res. 632:8. PubMed
  4. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  5. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
  6. Kawabe T, et al. 2020. Nat Commun. 2.795833333. PubMed
  7. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  8. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  9. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  10. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
  11. Minute L, et al. 2020. J Immunother Cancer. 8:. PubMed
  12. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  13. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  14. Gujar R, et al. 2016. J Immunol. 197: 1650 - 1662. PubMed
  15. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  16. Riva A, et al. 2013. J Immunol. 190:5961. PubMed
  17. Zhang LJ, et al. 2019. Immunity. 50:121. PubMed
  18. Shi L, et al. 2019. Theranostics. 9:4115. PubMed
  19. Page N, et al. 2018. Immunity. 48:937. PubMed
  20. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  21. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  22. Kitai H, et al. 2022. BMC Biol. 20:248. PubMed
  23. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  24. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  25. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
  26. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  27. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  28. Meng W, et al. 2021. JCI Insight. 6:. PubMed
  29. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  30. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  31. Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed
  32. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  33. Takeda Y, et al. 2018. Innate Immun. 24:323. PubMed
  34. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  35. Pandey S, et al. 2020. Cell Syst. 11:495. PubMed
  36. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 5:64. PubMed
  37. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  38. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  39. Nam J, et al. 2021. Adv Sci (Weinh). 2002577:8. PubMed
  40. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
  41. Coppo M, et al. 2016. Nat Commun. 7:12254. PubMed
  42. Wegmann F, et al. 2015. Clin Vaccine Immunol. 22: 1004-1012. PubMed
  43. Qian F, et al. 2015. J Mol Cell Biol. . PubMed
  44. He Y, et al. 2020. Sci Adv. 6:eaba7589. PubMed
  45. Blumenthal D, et al. 2020. eLife. 9:e55995.. PubMed
  46. Li Y, et al. 2020. Cell Rep. 30:1753. PubMed
  47. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  48. Shin M et al. 2019. Cell Chem Biol. 26(7):1036-1041 . PubMed
  49. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  50. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  51. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  52. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  53. Liang W, et al. 2022. Methods Mol Biol. 2574:221. PubMed
  54. Wiernicki B, et al. 2022. Nat Commun. 13:3676. PubMed
  55. Zhou X, et al. 2022. Front Pharmacol. 13:887263. PubMed
  56. Chen WS, et al. 2021. Cell Rep. 37:109974. PubMed
  57. Klarquist J, et al. 2021. Cell Rep. 36:109591. PubMed
  58. Prado C, et al. 2012. J Immunol. 188:3062. PubMed
  59. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  60. Bode K, et al. 2020. Cell Reports. 29(13):4435-4446.e9.. PubMed
  61. Wiede F, et al. 2021. Cancer Discov. Online ahead of print. PubMed
  62. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  63. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  64. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  65. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  66. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  67. O'Shea NR, Chew TS 2016. J Crohns Colitis. 10(12):1417-1427. PubMed
  68. Angelidis I, et al. 2019. Nat Commun. 10:963. PubMed
  69. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  70. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  71. Sharma PK, et al. 2018. Cancer Gene Ther. 25:27. PubMed
  72. Wang Y, et al. 2022. Front Immunol. 13:767630. PubMed
  73. Hao F, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  74. Kulkarni NN, et al. 2021. J Biol Chem. 297:100828. PubMed
  75. Dos Santos Dias L, et al. 2021. PLoS Pathog. e1009324:17. PubMed
  76. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  77. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  78. Lin SY, et al. 2017. Autophagy. 14:778. PubMed
  79. Yuan B, et al. 2021. J Immunother Cancer. 9:. PubMed
  80. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  81. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  82. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  83. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  84. Wang Y, et al. 2021. Sci Rep. 1.429861111. PubMed
  85. Sellau J, et al. 2016. Sci Rep. 6:28058. PubMed
  86. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  87. Madan-Lala R, et al. 2014. J Immunol. 192:4263. PubMed
  88. Bunn P, et al. 2014. J Immunol. 192:3709. PubMed
  89. Ustarroz-Cano M, et al. 2012. J Immunotoxicol. 9:374. PubMed
  90. Bak S, et al. 2008. Mol Immunol. 45:1414. PubMed
  91. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  92. Lisk C, et al. 2020. Front Immunol. 1.329166667. PubMed
  93. Gu H, et al. 2018. Aging (Albany NY). 1.525694444. PubMed
  94. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  95. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  96. Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed
  97. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  98. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  99. Stump CT, et al. 2021. Open Biol. 11:210245. PubMed
  100. Dokoshi T, et al. 2021. J Clin Invest. 131:. PubMed
  101. Glauser D, et al. 2013. J Virol. 87:10828. PubMed
  102. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  103. Spinner C, et al. 2015. Sci Rep. 5:16269. PubMed
  104. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  105. Li N, et al. 2021. eLife. 10:00. PubMed
  106. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  107. Gozgit JM, et al. 2021. Cancer Cell. :. PubMed
  108. Kooreman NG et al. 2018. Cell stem cell. 22(4):501-513 . PubMed
  109. Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed
  110. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  111. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  112. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  113. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  114. Zou J, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:983. PubMed
  115. Li W, et al. 2021. Front Pharmacol. 12:697483. PubMed
  116. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  117. Liu M, et al. 2016. PLoS One. 11:e0166165. PubMed
  118. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  119. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  120. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  121. Yadava K et al. 2019. Elife. 8 pii: e44821. PubMed
  122. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  123. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  124. Niknam S, et al. 2018. Clin Cancer Res. 24:5735. PubMed
  125. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  126. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  127. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  128. Xu M, et al. 2022. Genes Dis. 9:429. PubMed
  129. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  130. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  131. White C, et al. 2015. J Immunol. 194:697. PubMed
  132. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  133. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  134. Liu Z, et al. 2021. Immunity. 54(2):247-258.e7. PubMed
  135. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  136. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  137. Platteel A, et al. 2017. Vaccine.. 10.1016/j.vaccine.2017.10.044. PubMed
  138. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  139. He J, et al. 2019. J Clin Invest. 130. PubMed
  140. Kemp V, et al. 2018. Cancer Gene Ther. 26:268. PubMed
  141. Kramer K, et al. 2017. ACS Omega. 0.240972222. PubMed
  142. Liu W, et al. 2019. Epigenetics. 1.192361111. PubMed
  143. Marsh L, et al. 2009. Am J Physiol Lung Cell Mol Physiol. 296:L442. PubMed
  144. Yang Y, et al. 2021. Sci Adv. 7:eabf6290. PubMed
  145. Kim S, et al. 2021. Elife. 10:. PubMed
  146. Covarrubias AJ, et al. 2020. Nat Metab. 1265:2. PubMed
  147. Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed
  148. Dobson HE, et al. 2020. Mucosal Immunol. 0.901388889. PubMed
  149. Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
  150. Mainini F, et al. 2015. PLoS One. 10: 0145403. PubMed
  151. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  152. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
  153. Yahagi A, et al. 2019. RMD Open. 5:e000853. PubMed
  154. Xia P et al. 2018. Immunity. 48(4):688-701 . PubMed
  155. Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed
  156. Lang V, et al. 2021. Elife. 10:. PubMed
  157. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  158. Takaki H, et al. 2013. J Immunol. 191:4740. PubMed
  159. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  160. Ye Y, et al. 2017. Sci Immunol. 2:17. PubMed
  161. Zeng J, et al. 2018. J Immunol. 200:3407. PubMed
  162. Trinh HKT, et al. 2019. J Cell Mol Med. 23:3441. PubMed
  163. Fischer FA, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  164. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  165. Tukaramrao DB, et al. 2021. Cancers (Basel). 13:. PubMed
  166. Wüthrich M, et al. 2021. MBio. 12:e0201821. PubMed
  167. Schneider KM, et al. 2022. Nat Commun. 13:3964. PubMed
  168. Kohn EM, et al. 2022. J Immunol. 208:1417. PubMed
  169. Wang Y, et al. 2022. J Control Release. 349:118. PubMed
  170. Shan B, et al. 2020. Nat Metab. 1332:2. PubMed
  171. Zhao L, et al. 2021. STAR Protocols. 2:100732. PubMed
  172. Peng X, et al. 2016. J Cell Sci. 129: 1831 - 1842. PubMed
  173. Tozuka M, et al. 2016. J Dermatol Sci. 82: 38-45. PubMed
  174. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  175. Chitu V, et al. 2020. Cell Reports. 30(9):3004-3019. PubMed
  176. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  177. Yamada S, et al. 2018. Arterioscler Thromb Vasc Biol. 38:994. PubMed
  178. Chu LH, et al. 2018. Nat Commun. 9:996. PubMed
  179. Tang Z, et al. 2021. Stem Cell Res Ther. 12:397. PubMed
  180. Zhang XW, et al. 2021. Oncoimmunology. 10:1920739. PubMed
  181. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  182. Berthold N, et al. 2013. Antimicrob Agents Chemother. 57:402. PubMed
  183. Upadhya R, et al. 2016. MBio. 7: 00547-16. PubMed
  184. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  185. Li C, et al. 2018. Cell. 174:285. PubMed
  186. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  187. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  188. Carlson PM, et al. 2021. J Immunol. 207:720. PubMed
  189. Woodring T, et al. 2022. iScience. 25:104934. PubMed
  190. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  191. Zhao W, et al. 2014. Clin Vaccine Immunol. 21:74. PubMed
  192. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  193. Qian Z, et al. 2022. Biomedicines. 10:. PubMed
  194. Bezu L, et al. 2022. J Immunother Cancer. 10:. PubMed
  195. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  196. Vogel A, et al. 2022. Cell Rep. 38:110420. PubMed
  197. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  198. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  199. Cerina M, et al. 2017. Brain Behav Immun. 59:103-117. PubMed
  200. Kramer K, et al. 2017. Mol Ther. 25(1):62-70. PubMed
  201. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  202. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  203. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  204. Wang S, et al. 2020. J Cell Mol Med. 24:722. PubMed
  205. Dokoshi T, et al. 2020. Cell Rep. 30:61. PubMed
  206. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  207. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  208. Lisk C, et al. 2021. Front Immunol. 12:624197. PubMed
  209. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  210. Takahashi N, et al. 2022. Tohoku J Exp Med. 257:171. PubMed
  211. Grube J, et al. 2022. Cell Death Dis. 13:704. PubMed
  212. Liu Q, et al. 2021. Adv Mater. 33:e2102852. PubMed
  213. Sobecki M, et al. 2022. Cell Stem Cell. 29:1459. PubMed
  214. Ryu S, et al. 2021. eLife. 0.416666666666667. PubMed
  215. Wang Y, et al. 2021. Nat Commun. 0.570833333. PubMed
  216. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  217. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  218. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  219. Huang WC, et al. 2020. NPJ Vaccines. 5:23. PubMed
  220. Kunishita Y, et al. 2020. Front Immunol. 11:98. PubMed
  221. Wang C, et al. 2018. Sci Transl Med. 10. PubMed
  222. Dye BR, et al. 2020. Biomaterials. 234:119757. PubMed
  223. Shen H, et al. 2022. Nat Commun. 13:5013. PubMed
  224. Smith LK, et al. 2021. Elife. 10:. PubMed
  225. Harding CL, et al. 2020. Front Cell Infect Microbiol. 10:328. PubMed
  226. Li H, et al. 2022. iScience. 25:104481. PubMed
  227. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  228. Boulch M, et al. 2021. Sci Immunol. 6:. PubMed
  229. Nicholls J, et al. 2021. Front Cell Dev Biol. 9:737880. PubMed
  230. Huang WC, et al. 2020. NPJ Vaccines. 5:23. PubMed
  231. Gentschev I, et al. 2012. PLoS One. 7:e37239. PubMed
  232. Dyer DP et al. 2019. Immunity. 50(2):378-389 . PubMed
  233. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  234. Matisz CE, et al. 2018. Am J Pathol. 188:2589. PubMed
  235. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  236. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  237. Zhang B, et al. 2021. Nature. 599:471. PubMed
  238. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  239. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  240. Gawish R, et al. 2022. Elife. 11:. PubMed
  241. Cortez MA, et al. 2020. Nat Commun. 3.819444444. PubMed
  242. Brenner E, et al. 2020. Nat Commun. 11:1335. PubMed
  243. Morrissey MA, et al. 2018. Elife. 7:e36688. PubMed
  244. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  245. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  246. Yu L, et al. 2022. Front Immunol. 13:937331. PubMed
  247. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  248. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  249. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  250. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  251. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
  252. Rana MN, et al. 2021. Front Pharmacol. 12:643215. PubMed
RRID
AB_313778 (BioLegend Cat. No. 117309)
AB_313779 (BioLegend Cat. No. 117310)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Spark Blue™ 515 anti-mouse CD11c N418 FC
PerCP/Fire™ 806 anti-mouse CD11c N418 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account